Plantar Fasciitis Treatment Market

Plantar Fasciitis Treatment Market (Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Plantar Fasciitis Treatment Market Outlook 2031

  • The global industry was valued at US$ 778.3 Mn in 2022
  • It is estimated to grow at a CAGR of 4.3% from 2023 to 2031 and reach US$ 1.1 Bn by the end of 2031

Analyst Viewpoint

Significant increase in obese population across the globe is a prominent factor that is fostering plantar fasciitis treatment market development. Treatment for plantar fasciitis, an inflammation of the fibrous tissue along the bottom of the foot that connects the heel bone to toes, ranges from icing to heel pain surgery.

Rise in patient preference for hospitalization as compared to OTC treatment is also boosting the plantar fasciitis treatment industry value.

Companies operating in the global plantar fasciitis treatment market are devising technologically advanced products for plantar fasciitis for sportspersons, as athletes are highly prone to plantar fasciitis.

Key manufacturers of plantar fasciitis treatment products are following the latest plantar fasciitis treatment industry trends and offering customized products such as bespoke orthotic insoles as per personal clinical specifications to increase their industry share.

Market Introduction

Plantar fasciitis is a common condition in which the plantar fascia, a thick fibrous ligament that supports the arch of the foot and connects the heel bone to the toe, becomes strained and inflamed, causing discomfort and heel pain.

Inflammation or damage to plantar fascia results in plantar fasciitis. Obese people and sportspersons are at greater risk of plantar fasciitis. As per a National Center for health Statistics (NCHS) report, one million people are likely to contract plantar fasciitis every year.

Orthotic insoles, shockwave therapy, and anti-inflammatory drugs are various options available to reduce pain caused due to planar fasciitis.Types of plantar fasciitis treatment include stretching and physical therapy, icing and medication, rest, activity modification, and orthotics, shockwave therapy, steroid injections, and gastrocnemius recession.

Attribute Detail
Market Drivers
  • Surge in Obese Population
  • Increase in Patient Preference for Hospitalization for Treatment

Surge in Obese Population Worldwide Fueling Plantar Fasciitis Treatment Market Growth

Rise in adoption of sedentary lifestyle, especially after the onset of the COVID-19 pandemic, is one of the key factors that has led to an increase in prevalence of obesity across the globe.

The obese population is more prone to ankle and joint inflammation, which may cause plantar fasciitis. Thus, rise in obese population worldwide is creating lucrative plantar fasciitis treatment market opportunities for companies operating in the sector.

According to OECD data published in 2022, obesity and other weight-related issues are widespread across the globe. These disorders are more prevalent in the U.S. due to excessive consumption of fast food, especially among the younger population, in the country.

As per the WHO, over 1 billion people across the world are obese. Healthcare personnel state that if the body mass index (BMI) is 30 or higher, the risk of contracting plantar fasciitis is six times higher.

Increase in Patient Preference for Hospitalization for Treatment

People suffering from plantar fasciitis are increasingly opting for hospitalization, as symptoms related to the disorder such as inflammation and pain can be closely monitored by the healthcare personnel and subsequent course of action can be decided upon with immediate effect.

Painkillers such as steroids or NSAIDs are often administered to patients during the course of the treatment for plantar fasciitis. Side-effects of these medications can be better addressed through continuous monitoring during hospitalization.

Surgery is recommended if chronic heel pain continues even after adoption of remedies such as orthotic arch supports, splints, taping of foot, strengthening and stretching exercises, anti-inflammatory medications, massage, platelet-rich plasma injections, radiofrequency ablation, and extracorporeal shock wave therapy.

Decisions regarding plantar fasciitis surgery can be taken promptly during the course of hospitalization.Thus, increase in preference for hospitalization among people suffering from plantar fasciitis across the globe is one of the primary plantar fasciitis treatment market drivers.

Regional Outlook

Attribute Detail
Leading Region North America

North America dominated the global plantar fasciitis treatment landscape in 2022. The region is expected to maintain its leading share during the forecast period.

The plantar fasciitis treatment market forecast appears promising in North America owing to the surge in incidence of obesity and availability of strong healthcare infrastructure in the U.S. and Canada.According to the latest plantar fasciitis treatment market analysis, Europe is projected to record steady industry progress in the near future.

As per NICE, 7% of the older and 4% of the general population in the U.K. suffers from plantar fasciitis. It further mentions that 8% to 10% of regular runners are afflicted with plantar fasciitis, which needs professional treatment.

Analysis of Key Players

As per the latest plantar fasciitis treatment market insights, companies operating in the global plantar fasciopathy treatment landscape are engaging in new product launches to cater to the growing population of individuals afflicted with plantar fasciitis. For instance, Ottobock has introduced the Malleo Immobil Night Splint that stretches the foot to facilitate nighttime healing.

Key players are investing substantially in research and development activities to introduce products that use a combination of extracorporeal shock therapy and local vibration for effective treatment of chronic plantar fasciitis.

Hanger, Inc., Bayer Group (Dr. Scholl’s), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc are some of the leading players operating in the global landscape.

The plantar fasciitis treatment market report highlights parameters such as company overview, business strategies, financial overview, product portfolio, and business segments of these companies.

Key Development

  • In June 2022, Atlecko introduced its 12-piece plantar fasciitis socks kit. These are scientifically designed compression socks that help relieve pain arising from plantar fasciitis.

Plantar Fasciitis Treatment Market Snapshot

Attribute Detail
Market Size in 2022 US$ 778.3 Mn
Market Forecast (Value) in 2031 US$ 1.1 Bn
Growth Rate (CAGR) 4.3%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Mn/Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Type
    • Medication Therapy
      • Oral
      • Parenteral
    • Shockwave Therapy
      • Extracorporeal Shock Wave Therapy (ESWT)
      • Intracorporeal Pneumatic Shockwave Therapy (IPST))
    • Surgery
    • Orthotics
    • Others
  • End-user
    • Hospitals
    • Clinics
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Hanger, Inc.
  • Bayer Group (Dr. Scholl’s)
  • A. Algeo Limited
  • Bauerfeind AG
  • Superfeet Worldwide, Inc.
  • Ottobock SE & Co. KGaA (Ottobock Holding)
  • Pfizer, Inc.
  • Sanofi
  • GlaxoSmithKline plc
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global plantar fasciitis treatment market in 2022?

It was valued at US$ 778.3 Mn in 2022

How is the plantar fasciitis treatment business expected to grow during the forecast period?

It is projected to grow at a CAGR of 4.3% from 2023 to 2031

What are the key factors driving the demand for plantar fasciitis treatment?

Rise in obese population worldwide and growth in patient preference for hospitalization for treatment

Which plantar fasciitis treatment end-user segment held the largest share in 2022?

The hospitals segment accounted for the largest share in 2022

Which region dominated the global plantar fasciitis treatment landscape in 2022?

North America was the dominant region in 2022

Who are the key plantar fasciitis treatment manufacturers?

Hanger, Inc., Bayer Group (Dr. Scholl’s), A. Algeo Limited, Bauerfeind AG, Superfeet Worldwide, Inc., Ottobock SE & Co. KGaA (Ottobock Holding), Pfizer, Inc., Sanofi, and GlaxoSmithKline plc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Plantar Fasciitis Treatment Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Plantar Fasciitis Treatment Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Type, 2017–2031

            6.3.1. Medication Therapy

                6.3.1.1. Oral

                6.3.1.2. Parenteral

            6.3.2. Shockwave Therapy

                6.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

                6.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

            6.3.3. Surgery

            6.3.4. Orthotics

            6.3.5. Others

        6.4. Market Attractiveness Analysis, by Type

    7. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by End-user

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by End-user, 2017–2031

            7.3.1. Hospitals

            7.3.2. Clinics

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by End-user

    8. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Market Value Forecast, by Region, 2017–2031

            8.2.1. North America

            8.2.2. Europe

            8.2.3. Asia Pacific

            8.2.4. Latin America

            8.2.5. Middle East & Africa

        8.3. Market Attractiveness Analysis, by Region

    9. North America Plantar Fasciitis Treatment Market Analysis and Forecast

        9.1. Introduction

        9.2. Key Findings

        9.3. Market Value Forecast, by Type, 2017–2031

            9.3.1. Medication Therapy

                9.3.1.1. Oral

                9.3.1.2. Parenteral

            9.3.2. Shockwave Therapy

                9.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

                9.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

            9.3.3. Surgery

            9.3.4. Orthotics

            9.3.5. Others

        9.4. Market Value Forecast, by End-user, 2017–2031

            9.4.1. Hospitals

            9.4.2. Clinics

            9.4.3. Others

        9.5. Market Value Forecast, by Country, 2017–2031

            9.5.1. U.S.

            9.5.2. Canada

        9.6. Market Attractiveness Analysis

            9.6.1. By Type

            9.6.2. By End-user

            9.6.3. By Country

    10. Europe Plantar Fasciitis Treatment Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Type, 2017–2031

            10.3.1. Medication Therapy

                10.3.1.1. Oral

                10.3.1.2. Parenteral

            10.3.2. Shockwave Therapy

                10.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

                10.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

            10.3.3. Surgery

            10.3.4. Orthotics

            10.3.5. Others

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Hospitals

            10.4.2. Clinics

            10.4.3. Others

        10.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            10.5.1. Germany

            10.5.2. U.K.

            10.5.3. France

            10.5.4. Italy

            10.5.5. Spain

            10.5.6. Rest of Europe

        10.6. Market Attractiveness Analysis

            10.6.1. By Type

            10.6.2. By End-user

            10.6.3. By Country/Sub-region

    11. Asia Pacific Plantar Fasciitis Treatment Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Type, 2017–2031

            11.3.1. Medication Therapy

                11.3.1.1. Oral

                11.3.1.2. Parenteral

            11.3.2. Shockwave Therapy

                11.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

                11.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

            11.3.3. Surgery

            11.3.4. Orthotics

            11.3.5. Others

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Hospitals

            11.4.2. Clinics

            11.4.3. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. China

            11.5.2. Japan

            11.5.3. India

            11.5.4. Australia & New Zealand

            11.5.5. Rest of Asia Pacific

        11.6. Market Attractiveness Analysis

            11.6.1. By Type

            11.6.2. By End-user

            11.6.3. By Country/Sub-region

    12. Latin America Plantar Fasciitis Treatment Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Type, 2017–2031

            12.3.1. Medication Therapy

                12.3.1.1. Oral

                12.3.1.2. Parenteral

            12.3.2. Shockwave Therapy

                12.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

                12.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

            12.3.3. Surgery

            12.3.4. Orthotics

            12.3.5. Others

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Hospitals

            12.4.2. Clinics

            12.4.3. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. Brazil

            12.5.2. Mexico

            12.5.3. Rest of Latin America

        12.6. Market Attractiveness Analysis

            12.6.1. By Type

            12.6.2. By End-user

            12.6.3. By Country/Sub-region

    13. Middle East & Africa Plantar Fasciitis Treatment Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Type, 2017–2031

            13.3.1. Medication Therapy

                13.3.1.1. Oral

                13.3.1.2. Parenteral

            13.3.2. Shockwave Therapy

                13.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)

                13.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)

            13.3.3. Surgery

            13.3.4. Orthotics

            13.3.5. Others

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Hospitals

            13.4.2. Clinics

            13.4.3. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. GCC Countries

            13.5.2. South Africa

            13.5.3. Rest of Middle East & Africa

        13.6. Market Attractiveness Analysis

            13.6.1. By Type

            13.6.2. By End-user

            13.6.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        14.2. Market Share Analysis, by Company (2022)

        14.3. Company Profiles

            14.3.1. Hanger, Inc.

                14.3.1.1. Company Overview

                14.3.1.2. Product Portfolio

                14.3.1.3. SWOT Analysis

                14.3.1.4. Financial Overview

                14.3.1.5. Strategic Overview

            14.3.2. Bayer Group (Dr. Scholl’s)

                14.3.2.1. Company Overview

                14.3.2.2. Product Portfolio

                14.3.2.3. SWOT Analysis

                14.3.2.4. Financial Overview

                14.3.2.5. Strategic Overview

            14.3.3. A. Algeo Limited

                14.3.3.1. Company Overview

                14.3.3.2. Product Portfolio

                14.3.3.3. SWOT Analysis

                14.3.3.4. Financial Overview

                14.3.3.5. Strategic Overview

            14.3.4. Bauerfeind AG

                14.3.4.1. Company Overview

                14.3.4.2. Product Portfolio

                14.3.4.3. SWOT Analysis

                14.3.4.4. Financial Overview

                14.3.4.5. Strategic Overview

            14.3.5. Superfeet Worldwide, Inc.

                14.3.5.1. Company Overview

                14.3.5.2. Product Portfolio

                14.3.5.3. SWOT Analysis

                14.3.5.4. Financial Overview

                14.3.5.5. Strategic Overview

            14.3.6. Ottobock SE & Co. KGaA (Ottobock Holding)

                14.3.6.1. Company Overview

                14.3.6.2. Product Portfolio

                14.3.6.3. SWOT Analysis

                14.3.6.4. Financial Overview

                14.3.6.5. Strategic Overview

            14.3.7. Pfizer, Inc.

                14.3.7.1. Company Overview

                14.3.7.2. Product Portfolio

                14.3.7.3. SWOT Analysis

                14.3.7.4. Financial Overview

                14.3.7.5. Strategic Overview

            14.3.8. Sanofi

                14.3.8.1. Company Overview

                14.3.8.2. Product Portfolio

                14.3.8.3. SWOT Analysis

                14.3.8.4. Financial Overview

                14.3.8.5. Strategic Overview

            14.3.9. GlaxoSmithKline plc

                14.3.9.1. Company Overview

                14.3.9.2. Product Portfolio

                14.3.9.3. SWOT Analysis

                14.3.9.4. Financial Overview

                14.3.9.5. Strategic Overview

    List of Tables

    Table 01: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 02: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 03: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 04: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 05: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 06: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 07: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 08: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 11: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 12: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 13: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 14: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 15: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 16: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017–2031

    Table 17: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 18: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    List of Figures

    Figure 01: Global Plantar Fasciitis Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

    Figure 02: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by Type, 2022

    Figure 03: Global Plantar Fasciitis Treatment Market Value Share, by Type, 2022

    Figure 04: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by End-user, 2022

    Figure 05: Global Plantar Fasciitis Treatment Market Value Share, by End-user, 2022

    Figure 06: Global Plantar Fasciitis Treatment Market Value Share, by Region, 2022

    Figure 07: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, 2023–2031

    Figure 08: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

    Figure 09: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

    Figure 10: Global Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 11: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 12: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Region, 2022–2031

    Figure 13: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Region, 2023–2031

    Figure 14: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 15: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country, 2023–2031

    Figure 16: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Country, 2022–2031

    Figure 17: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

    Figure 18: North America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 19: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

    Figure 20: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 21: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 22: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 23: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 24: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

    Figure 25: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 26: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

    Figure 27: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 28: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 29: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 30: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 31: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

    Figure 32: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 33: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

    Figure 34: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 35: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 36: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 37: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 38: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

    Figure 39: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 40: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

    Figure 41: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

    Figure 42: Middle East & Africa Plantar Fasciitis Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 43: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 44: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022–2031

    Figure 45: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022–2031

    Figure 46: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022–2031

    Figure 47: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023–2031

    Figure 48: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved